Recent Patents on Regenerative Medicine
Title:Patent Selections:
Volume: 5 Issue: 1
Export Options
About this article
Cite this article as:
Patent Selections:, Recent Patents on Regenerative Medicine 2015; 5 (1) . https://dx.doi.org/10.2174/221029650501150702134737
DOI https://dx.doi.org/10.2174/221029650501150702134737 |
Print ISSN 2210-2965 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-2973 |
Related Books
20
Related Articles
-
Magnetic Resonance-Based Metabolomics for Understanding Neurological Disorders: Current Status and Statistical Considerations
Current Metabolomics Commentary((Research Highlights)(Amyotrophic Lateral Sclerosis: Targeting the Body’s Energy Engine))
CNS & Neurological Disorders - Drug Targets Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases
Current Drug Targets Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Current Alzheimer Research Targeting PPAR Isoforms Following CNS Injury
Current Drug Targets Current and Promising Therapies in Autosomal Recessive Ataxias
CNS & Neurological Disorders - Drug Targets Purines and Pyrimidines: Metabolism, Function and Potential as Therapeutic Options in Neurodegenerative Diseases
Current Protein & Peptide Science PET Radioligands for In Vivo Visualization of Neuroinflammation
Current Pharmaceutical Design Microglial Senescence
CNS & Neurological Disorders - Drug Targets Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Current Medicinal Chemistry Nitric Oxide Homeostasis in Neurodegenerative Diseases
Current Alzheimer Research Patent Selections
Recent Patents on Food, Nutrition & Agriculture Editorial (Hot Topic: Organic Solute Transporters and Diseases: Potential Therapeutic Targets)
Current Molecular Pharmacology Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
Current Molecular Medicine Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
Current Neuropharmacology Pharmacological Approaches to Chronic Spinal Cord Injury
Current Pharmaceutical Design Integrated Analysis of Transcriptomic and Proteomic Data
Current Genomics Evaluation of the Performance of Manganese Phthalocyanines as Superoxide Dismutase Mimics
Current Analytical Chemistry Mechanisms of Oxidative Glutamate Toxicity: The Glutamate/Cystine Antiporter System xc¯ as a Neuroprotective Drug Target
CNS & Neurological Disorders - Drug Targets Isoprostanes as Biomarkers and Mediators of Oxidative Injury in Infant and Adult Central Nervous System Diseases
Current Neurovascular Research